A detailed history of Park Capital Management, LLC / Wi transactions in Exact Sciences Corp stock. As of the latest transaction made, Park Capital Management, LLC / Wi holds 2,305 shares of EXAS stock, worth $154,504. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,305
Holding current value
$154,504
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 20, 2026

BUY
$56.19 - $69.63 $129,517 - $160,497
2,305 New
2,305 $234 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Park Capital Management, LLC / Wi Portfolio

Follow Park Capital Management, LLC / Wi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Capital Management, LLC / Wi, based on Form 13F filings with the SEC.

News

Stay updated on Park Capital Management, LLC / Wi with notifications on news.